Repligen (NasdaqGS:RGEN) 2025 Conference Transcript

Repligen (NasdaqGS:RGEN) 2025 Conference November 11, 2025 10:00 AM ET Company ParticipantsDan Arias - Managing DirectorOlivier Loeillot - President, CEO and DirectorDan AriasQuarter. I've been wrapping up the quarter for a lot of these sessions as a kickoff for Repligen. It was a good quarter. It was 18% organic growth. Each of the key product areas was up double digits. Op margins were 14.2% down 70 basis points. You beat the street by $0.05 on the bottom line. Maybe just talk a little bit about what got ...